Adverse drug reactions in patients visiting a general hospital: A meta-analysis of results;Reacciones adversas a medicamentos en pacientes que acudieron a un hospital general: Un meta-análisis de resultados

Anales de Medicina Interna

Volumn 24, Issue 12, 2007, Pages 574-578

  Puche Cañas, Emilio ^a,c   Luna Del Castillo, J D ^b  

^a HOSPITAL UNIVERSITARIO SAN CECILIO   (Spain)

^b UNIVERSITY OF GRANADA   (Spain)

^c UNIVERSITY OF GRANADA   (Spain)

Author keywords

Adverse drug reactions; Hospital; Hospital emergencies; Hospitalized patients

Indexed keywords

ACETYLSALICYLIC ACID; ADRENERGIC RECEPTOR STIMULATING AGENT; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIDIABETIC AGENT; ANTIINFECTIVE AGENT; BENZODIAZEPINE DERIVATIVE; BRONCHODILATING AGENT; CALCIUM ANTAGONIST; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIPYRONE; FUROSEMIDE; INSULIN; NEUROLEPTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; SALBUTAMOL; SULFONYLUREA;

ADVERSE OUTCOME; AGE; ARTICLE; CARDIOVASCULAR SYSTEM; CLINICAL OBSERVATION; COMORBIDITY; DIGESTIVE SYSTEM; EMERGENCY WARD; GENDER; GENERAL HOSPITAL; HOSPITAL ADMISSION; HUMAN; NERVOUS SYSTEM; PRESCRIPTION; PROGNOSIS; PUBLICATION; RISK FACTOR; SKIN; SPAIN; SYMPTOMATOLOGY; UNSPECIFIED SIDE EFFECT;

DRUG TOXICITY; EMERGENCIES; EMERGENCY SERVICE, HOSPITAL; HOSPITALS, GENERAL; HUMANS;

EID: 41549110162     PISSN: 02127199     EISSN: 02127199     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Einarson TR. Drug-related hospital admissions. Ann Pharmacother 1993; 27: 832-40
2. Lazarou J, Pomeranz B, Corey P. Incidente of adverse drug reactions in hospitalizad patients. A meta-analysis of prospective studies. JAMA 1998; 279: 1200-5.
3. Beijer Hl, Blaey CJ. Hospitalizations caused by adverse drug reactions (ADR): A meta-analysis of observational studies. Pharm World Sci 2002; 24: 46-54.
4. Wiffen P, Gill M, Edwards J, Moore A. Adverse drug reactions in hospital patients. Disponible en: www.ebandolier.com
5. Pirmohamed M, James S, Meakin S, Scott A, Walley T, et al. Adverse drug reactions as cause of admission to hospital: Prospective analysis of 18,820 patients. Br Med J 2004; 329: 15-9.
6. Puche E, Luna JD. Racciones adversas a medicamentos: Una revisión actualizada del problema en España. Rev Clin Esp 2006; 206: 336-9.
7. De Abajo FJ, Frías J, Lopo CR, Garijo B, Castro MA, Carcas A, Juárez S, Gil A. Las reacciones adversas a medicamentos como motivo de consulta al servicio de urgencias de un hospital general. Med Clin (Barc) 1989; 92: 530-5.
8. Guemes M, Sanz E, García M. Reacciones adversas y problemas relacionados con medicamentos en un servicio de urgencia. Rev Esp Salud Pública 1999; 73: 511-8.
9. DerSimonian R, Laird N. Meta-analysis in clinical trials. Controlled Clin Trials 1986; 7: 177-88.
10. Walker J, Wynne H. Review: The frecuency and severity of adverse drug reactions in elderly people: Age Aging 1994; 23: 255-9.
11. Roughead E, Gilbert A, Primrose J, Sasom LL. Drug-related hospital admissions: A review of Australian studies published 1988-1996. Med J Aust 1998; 168: 405-8.
12. Manesse C, Derk FH, De Ridder M. Contribution of adverse drug reactions to hospital admission of older patients. Age Aging 2000; 29: 35-9.
13. Onder G, Pedone C, Landi F, Cesri M, Della Vedova C, Bernabei R Gambassi G. Adverse drug reactions as cause of hospital admissions: Results from the Italian Group of Pharmacoepidemiology in the Elderly (GIFA). J Am Geriatr Soc 2002; 50: 1962-8.
14. Puche E, Luna JD, García J, Góngora L. Reacciones adversas a medicamentos de pronóstico grave en ancianos institucionalizados. Rev Esp Geriatr Gerontol 2003; 38: 193-7.
15. Somers A, Petrovic M, Robays H, Bogaert M. Reporting adverse drug reactions on a geriatric ward: A pilot project. Eur J Clin Pharmacol 2003; 58: 707-14.
16. Impicciatore P, Choonara I, Clarkson A, Provasi D, Pandolfini C, Bonati M. Incidence of adverse drug reactions in paediatric in/out patients: A systematic review and meta-analysis of prospective studies. Br J Clin Pharmacol 2001; 52: 77-83.
17. Rathore S, Wang Y, krumholz H. Sex-based differences in the effect of digoxin for the treatment of heart failure. N Engl J Med 2002; 347: 1403-11.
18. Puche E, Aomar I, Carrillo JC. Niveles inapropiados de digoxina en sangre relativos a 2.849 pacientes procedentes de un hospital universitario: Influencia de la edad y el sexo. An Med Interna (Madrid) 2004: 21: 581-4.
19. Drici M, Clement N. Is gender a risk factor for adverse drug reactions? The example of drug-induce long QT syndrome. Dug Saf 2001; 24: 575-85.
20. Martin R, Biswas P, Freemantle S, Pearce G, Mann R. Age and sex distribution of suspected adverse drug reactions to newly marketed drugs in general practice in England: Analysis of 48 cohort studies. Br J Clin Pharmacol 1998; 46: 505-11.
21. Tran C, Knowles S, Liu B, Shear N. Gender differences in adverse drug reactions. J Clin Pharmacol 1998; 38; 1003-9.
22. Eaton L. Adverse reactions to drugs increase. Br Med J 2002; 324: 8.
23. Gautier S, Bachelet H, Bordet R, Caron J. The cost of adverse drug reactions. Expert Opin Pharmacother 2003; 4: 319-26.
24. Lundkvist J, Jönsson B. Pharmacoeconomics of adverse drug reactions. Fundam Clin Pharmacol 2004; 18: 275-80.
25. Moore N, Lecointre D, Noblet C, Mabille M. Frequency and cost of serious adverse drud reactions in a department of general medicine. Br J Clin Pharmacol 1998; 45: 301-8.
26. Jhonson JA, Bootman JL. Drug-related morbility and mortality. A cost of illness model. Arch Intern Med 1995; 155: 1949-56.
27. Belton KJ. Attitude survey of adverse drug reactions reporting by health care professionals across the European Union. The European Pharmacovigilance Research Group. Eur J Clin Pharmacol 1997; 52: 423-7.
28. Laporte JR, Arnau JM. La detección de reacciones adversas por vigilancia intensiva en pacientes hospitalizados. En: Principios de epidemiología del medicamento. Laporte JR, Tognoni G, editores. Barcelona: Salvat Editores S.A.; 1983. p. 223-5.
29. Moride Y, Aramburu F, Requejo A, Bégaud B. Under reporting of adverse drug reactions in general practice. Br J Clin Pharmacol 1997; 43: 177-81.
30. Bäckström M, Mjörndal T, Dahlqvist R. Under reporting of serious adverse drug reactions in Sweden. Pharmacoepidemiol Drug Saf 2004; 13: 483-7.